Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)

NCT05382364 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic HER2+ Advanced Breast Cancer
Breast Neoplasms
Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
Colorectal Cancer

Interventions

DRUG: Tucatinib

Sponsor

Pfizer